Seth Rudnick - 17 Jun 2021 Form 4 Insider Report for G1 Therapeutics, Inc.

Role: Director
Signature: /s/ James Stillman Hanson, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 17 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 21 Jun 2021, 16:06:07 UTC
Next filing: 30 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GTHX	Common Stock	Award	$0	+4,389		$0.000000	4,389	17 Jun 2021	Direct	F1, F2
holding	GTHX	Common Stock						5,266	17 Jun 2021	See Footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GTHX	Stock Options (Right to Buy)	Award	$0	+19,620		$0.000000	19,620	17 Jun 2021	Common Stock	19,620	$21.97	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director.
F2	Each RSU represents a contingent right to receive one share of Issuer common stock
F3	These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F4	The shares underlying this option will vest in their entirety twelve months after June 17, 2021, subject to the Reporting Person's continued service as a director.